| Autor: |
Al-Bakaa MK; Department of Medicine, University of Jabir ibn Hayyan College of Medicine, Najaf 54006, Iraq., Al-Dhalimi MA; Department of Medicine, University of Kufa College of Medicine, Najaf 54006, Iraq., Dube P; Department of Medicine, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43606, USA., Khalaf FK; Department of Medicine, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43606, USA.; Department of Clinical Pharmacy, University of Alkafeel College of Pharmacy, Najaf 54006, Iraq. |
| Jazyk: |
angličtina |
| Zdroj: |
Journal of clinical medicine [J Clin Med] 2022 Jul 21; Vol. 11 (14). Date of Electronic Publication: 2022 Jul 21. |
| DOI: |
10.3390/jcm11144230 |
| Abstrakt: |
Becker's nevus (BN) is a cutaneous hamartoma of benign nature that develops through adolescence and affects mostly young men. The nevus is usually located unilaterally and is characterized by hypertrichosis and hyperpigmentation. Despite recent advances in treatment modalities, no effective treatment has been established for BN hyperpigmentation. We sought to assess the efficacy and safety of fractional Erbium: YAG 2940 nm and Q-switched Nd: YAG 1064 nm lasers in the treatment of BN hyperpigmentation. Twenty-three patients with BN were included in a prospective, randomized-controlled, observer-blinded, split-lesion comparative technique trial. In each patient, two similar square test regions were randomized to either be treated with a fractional Erbium: YAG 2940 nm laser or with a Q-switched Nd: YAG 1064 nm laser. Each patient was treated with three sessions at six-week intervals. At the follow-up, clearance of hyperpigmentation was assessed by physician global assessment, visual analogue scale, grade of improvement, patient global assessment, and patient satisfaction. Regions treated with the fractional Erbium: YAG 2940 nm laser demonstrated significantly better improvement compared to ones treated with the Q-switched Nd: YAG 1064 nm ( p -value = 0.001) laser. Adverse effects such as repigmentation and hypertrophic scarring were not reported during the follow-up period. The outcomes were cosmetically acceptable with overall high satisfaction among the included patients. Our data suggest a superior role for the fractional Erbium: YAG (2940 nm) laser in the treatment of BN hyperpigmentation compared to the Q-switched Nd: YAG (1064 nm) laser, along with being a safer method and having no reported side effects. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
|
Nepřihlášeným uživatelům se plný text nezobrazuje |
K zobrazení výsledku je třeba se přihlásit.
|
